Sylvain Ferrandon
Biochemistry, Genetics and Molecular Biology · The Ohio State University
Publications
71
Citations
610
Est. group size
~11
Recurring co-author estimate
Active years
15
Publishing since 2012
Sylvain Ferrandon studies colorectal and rectal cancer, focusing on how factors like gut bacteria (such as Fusobacterium nucleatum and Candida albicans), tumor oxygen levels (hypoxia), and cell metabolism pathways influence tumor growth and resistance to treatments such as radiation and chemotherapy. This work aims to identify biological markers and mechanisms that could explain why some tumors resist standard therapies. Students interested in cancer biology, the gut microbiome's role in disease, and treatment resistance mechanisms may find this research area relevant.
Publication output was modest and steady from 2017-2022, spiked sharply in 2023 (likely due to a cluster of supplementary materials from a few studies), dropped to zero in 2024, and has resumed at a low level in 2025-2026.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- Abstract 962: Phenylacetaldehyde induces apoptosis through endoplasmic reticulum stress and potentiates the effect of 5-FU treatment in colorectal cancer
Cancer Research · 2026
- Abstract 7379: FDXR expression is a rectal cancer biomarker of radiation resistance and confers resistance through ferroptosis
Cancer Research · 2026
- Abstract 6521: Tumor colonization with <i>Candida albicans</i> increases tumor growth and decreases treatment response by influencing tumor hypoxia and immune activity
Cancer Research · 2025
- Redefining familial adenomatous polyposis: competition, cooperation, and the path to monoclonality
Familial Cancer · 2025
- Table S8 from <i>Fusobacterium Nucleatum</i> Promotes the Development of Colorectal Cancer by Activating a Cytochrome P450/Epoxyoctadecenoic Acid Axis via TLR4/Keap1/NRF2 Signaling
2023
- Data from <i>Fusobacterium Nucleatum</i> Promotes the Development of Colorectal Cancer by Activating a Cytochrome P450/Epoxyoctadecenoic Acid Axis via TLR4/Keap1/NRF2 Signaling
2023
- Data from CoA Synthase (<i>COASY</i>) Mediates Radiation Resistance via PI3K Signaling in Rectal Cancer
2023
- Supplementary Table 1 from CoA Synthase (<i>COASY</i>) Mediates Radiation Resistance via PI3K Signaling in Rectal Cancer
2023
- Supplementary Figure 5 from CoA Synthase (<i>COASY</i>) Mediates Radiation Resistance via PI3K Signaling in Rectal Cancer
2023
- Supplementary Table 1 from CoA Synthase (<i>COASY</i>) Mediates Radiation Resistance via PI3K Signaling in Rectal Cancer
2023
- Supplementary Figure legends from CoA Synthase (<i>COASY</i>) Mediates Radiation Resistance via PI3K Signaling in Rectal Cancer
2023
- Supplementary Material and Method from CoA Synthase (<i>COASY</i>) Mediates Radiation Resistance via PI3K Signaling in Rectal Cancer
2023
- Supplementary Material and Method from CoA Synthase (<i>COASY</i>) Mediates Radiation Resistance via PI3K Signaling in Rectal Cancer
2023
- Supplementary Figure legends from CoA Synthase (<i>COASY</i>) Mediates Radiation Resistance via PI3K Signaling in Rectal Cancer
2023
- Supplementary Figure 5 from CoA Synthase (<i>COASY</i>) Mediates Radiation Resistance via PI3K Signaling in Rectal Cancer
2023
- Cancer Research×10
- Oncotarget×2
- Nature Communications×1
- British Journal of Cancer×1
- Surgical Endoscopy×1
- Nicholas Denko
Biochemistry, Genetics and Molecular Biology · The Ohio State University
- Jinghai Wu
Biochemistry, Genetics and Molecular Biology · The Ohio State University
- Chaylen Andolino
Biochemistry, Genetics and Molecular Biology · Purdue University West Lafayette
- Jade M. Katinas
Biochemistry, Genetics and Molecular Biology · Indiana University
- Fouad Choueiry
Biochemistry, Genetics and Molecular Biology · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile